STATCenter·
STAT+: PepGen says early trial for muscular dystrophy drug looks promising
PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.
Read at STAT →
Health · 1 sources covering this
STAT+: PepGen says early trial for muscular dystrophy drug looks promising
PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/da87eae451722b0d5fe810a2619fe775e4f87431" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: PepGen says early trial for muscular dystrophy drug looks promising"></iframe>
